Search Details

Word: kindler (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

...medical schools are a new low. After the Times stories were published, Senator Charles Grassley, an Iowa Republican and longtime critic of drug-company influence, fired off a letter to Pfizer chairman and CEO Jeffrey Kindler describing himself as "greatly disturbed" by the reports and accusing Pfizer of trying to "intimidate young scholars." Grassley cited the 149 Harvard professors or instructors who have received payments or benefits from Pfizer specifically and demanded a detailed accounting of all of them. He closed with a terse "I look forward to hearing from you by no later than March 10, 2009." Pfizer...

Author: /time Magazine | Title: Is Drug-Company Money Tainting Medical Education? | 3/6/2009 | See Source »

...Jeffrey Kindler...

Author: /time Magazine | Title: People to Watch In International Business | 8/20/2006 | See Source »

Bosses of pharmaceutical companies tend to have a background in science or medicine. Jeffrey Kindler, 51, took a different path to the top of Pfizer, a position he won in July when Pfizer's board chose him to replace Henry McKinnell. A Harvard-educated lawyer, Kindler represented corporate clients from General Electric to McDonald's before joining Pfizer in 2002. He also did a stint as CEO of McDonald's shaky Boston Market restaurant chain...

Author: /time Magazine | Title: People to Watch In International Business | 8/20/2006 | See Source »

...largest drug company? Saving it in court. The company is facing a flood of legal challenges. Among them: drugmaker Novo Nordisk recently claimed patent infringements for Pfizer's upcoming inhaled-insulin drug, Exubera, and Pfizer is being sued over Celebrex, its controversial Cox-2 inhibitor pain medication. Bonus points: Kindler knows his way around Washington, which should help Pfizer navigate the regulatory swamp. He has some operations cred too. At McDonald's, he led the turnaround of Boston Market...

Author: /time Magazine | Title: People to Watch In International Business | 8/20/2006 | See Source »

...Pfizer's share price has slumped more than 30% since 2001. Former CEO McKinnell didn't help matters, appearing aloof to investor concerns while pocketing more than $140 million during his tenure, including a retirement package worth an estimated $83 million. Mending fences with shareholders will be critical for Kindler. They are, after all, paying his salary...

Author: /time Magazine | Title: People to Watch In International Business | 8/20/2006 | See Source »

| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next